Industry: Medical Devices & Consumables
Published Date: 2024-02-05
Pages: 98 Pages
Report ld: 2421079
Request Sample
Customized Report
Paclitaxel-Coated PTA Balloon Catheter Market Size(US$)

CAGR 2024-2030
4.9%
Market Size,2030
USD 325.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A paclitaxel-coated PTA balloon catheter is a specialized medical device used in interventional cardiology and vascular interventions. It is designed to dilate narrowed or blocked blood vessels (arteries or veins) in a procedure known as angioplasty. The catheter is coated with paclitaxel, a drug that inhibits cell proliferation and helps prevent restenosis, which is the re-narrowing of the treated blood vessel after angioplasty.
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 233 million in 2023 and is anticipated to reach US$ 325.1 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
The demand for paclitaxel-coated PTA balloon catheters has grown significantly over the years due to their potential to improve long-term outcomes in patients undergoing angioplasty. These devices are used in interventional cardiology and vascular surgery settings worldwide.
The effectiveness of paclitaxel-coated PTA balloon catheters in reducing restenosis rates and improving clinical outcomes has been demonstrated in various clinical studies and trials. The ongoing research and development in the field contribute to the expansion of the market and the improvement of catheter designs.
The global paclitaxel-coated PTA balloon catheter market has shown significant potential for growth due to its clinical benefits and increasing adoption in various healthcare facilities. Key players in the medical device industry are actively involved in the development and commercialization of these devices, contributing to market competition and innovation.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel-Coated PTA Balloon Catheter, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel-Coated PTA Balloon Catheter.
MARKET SEGMENTATION
REPORT SCOPE
The Paclitaxel-Coated PTA Balloon Catheter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel-Coated PTA Balloon Catheter market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel-Coated PTA Balloon Catheter manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel-Coated PTA Balloon Catheter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel-Coated PTA Balloon Catheter in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Paclitaxel-Coated PTA Balloon Catheter Market Overview
1.1 Product Overview and Scope of Paclitaxel-Coated PTA Balloon Catheter
1.2 Paclitaxel-Coated PTA Balloon Catheter Segment by Type
1.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Market Value Comparison by Type (2024-2030)
1.2.2 Balloon Diameter 2-4 mm
1.2.3 Balloon Diameter 4-8 mm
1.2.4 Others
1.3 Paclitaxel-Coated PTA Balloon Catheter Segment by Application
1.3.1 Global Paclitaxel-Coated PTA Balloon Catheter Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Paclitaxel-Coated PTA Balloon Catheter Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel-Coated PTA Balloon Catheter Revenue 2019-2030
1.4.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales 2019-2030
1.4.3 Global Paclitaxel-Coated PTA Balloon Catheter Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel-Coated PTA Balloon Catheter Market Competition by Manufacturers
2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel-Coated PTA Balloon Catheter Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel-Coated PTA Balloon Catheter Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel-Coated PTA Balloon Catheter, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel-Coated PTA Balloon Catheter, Product Type & Application
2.7 Paclitaxel-Coated PTA Balloon Catheter Market Competitive Situation and Trends
2.7.1 Paclitaxel-Coated PTA Balloon Catheter Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel-Coated PTA Balloon Catheter Players Market Share by Revenue
2.7.3 Global Paclitaxel-Coated PTA Balloon Catheter Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel-Coated PTA Balloon Catheter Retrospective Market Scenario by Region
3.1 Global Paclitaxel-Coated PTA Balloon Catheter Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel-Coated PTA Balloon Catheter Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region: 2019-2030
3.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region: 2019-2024
3.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region: 2025-2030
3.3 Global Paclitaxel-Coated PTA Balloon Catheter Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region: 2025-2030
3.4 North America Paclitaxel-Coated PTA Balloon Catheter Market Facts & Figures by Country
3.4.1 North America Paclitaxel-Coated PTA Balloon Catheter Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel-Coated PTA Balloon Catheter Sales by Country (2019-2030)
3.4.3 North America Paclitaxel-Coated PTA Balloon Catheter Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel-Coated PTA Balloon Catheter Market Facts & Figures by Country
3.5.1 Europe Paclitaxel-Coated PTA Balloon Catheter Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel-Coated PTA Balloon Catheter Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel-Coated PTA Balloon Catheter Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel-Coated PTA Balloon Catheter Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paclitaxel-Coated PTA Balloon Catheter Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel-Coated PTA Balloon Catheter Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel-Coated PTA Balloon Catheter Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel-Coated PTA Balloon Catheter Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Type (2019-2030)
4.1.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Type (2019-2024)
4.1.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Type (2025-2030)
4.1.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel-Coated PTA Balloon Catheter Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application (2019-2030)
5.1.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application (2019-2024)
5.1.2 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application (2025-2030)
5.1.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel-Coated PTA Balloon Catheter Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Cardionovum
6.3.1 Cardionovum Corporation Information
6.3.2 Cardionovum Description and Business Overview
6.3.3 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.3.5 Cardionovum Recent Developments/Updates
6.4 QT Vascular
6.4.1 QT Vascular Corporation Information
6.4.2 QT Vascular Description and Business Overview
6.4.3 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.4.5 QT Vascular Recent Developments/Updates
6.5 Meril Life Sciences
6.5.1 Meril Life Sciences Corporation Information
6.5.2 Meril Life Sciences Description and Business Overview
6.5.3 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.5.5 Meril Life Sciences Recent Developments/Updates
6.6 Aachen Resonance Entwicklungsgesellschaft
6.6.1 Aachen Resonance Entwicklungsgesellschaft Corporation Information
6.6.2 Aachen Resonance Entwicklungsgesellschaft Description and Business Overview
6.6.3 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.6.5 Aachen Resonance Entwicklungsgesellschaft Recent Developments/Updates
6.7 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotronik Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Hemoteq
6.8.1 Hemoteq Corporation Information
6.8.2 Hemoteq Description and Business Overview
6.8.3 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.8.5 Hemoteq Recent Developments/Updates
6.9 Eucatech
6.9.1 Eucatech Corporation Information
6.9.2 Eucatech Description and Business Overview
6.9.3 Eucatech Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eucatech Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.9.5 Eucatech Recent Developments/Updates
6.10 B.Braun
6.10.1 B.Braun Corporation Information
6.10.2 B.Braun Description and Business Overview
6.10.3 B.Braun Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.10.4 B.Braun Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.10.5 B.Braun Recent Developments/Updates
6.11 Biosensors International
6.11.1 Biosensors International Corporation Information
6.11.2 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.11.3 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.11.5 Biosensors International Recent Developments/Updates
6.12 Eurocor
6.12.1 Eurocor Corporation Information
6.12.2 Eurocor Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.12.3 Eurocor Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eurocor Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.12.5 Eurocor Recent Developments/Updates
6.13 Invamed
6.13.1 Invamed Corporation Information
6.13.2 Invamed Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.13.3 Invamed Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Invamed Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.13.5 Invamed Recent Developments/Updates
6.14 IVascular
6.14.1 IVascular Corporation Information
6.14.2 IVascular Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.14.3 IVascular Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.14.4 IVascular Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.14.5 IVascular Recent Developments/Updates
6.15 Lutonix
6.15.1 Lutonix Corporation Information
6.15.2 Lutonix Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.15.3 Lutonix Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Lutonix Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.15.5 Lutonix Recent Developments/Updates
6.16 Zylox-Tonbridge
6.16.1 Zylox-Tonbridge Corporation Information
6.16.2 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Description and Business Overview
6.16.3 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Product Portfolio
6.16.5 Zylox-Tonbridge Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel-Coated PTA Balloon Catheter Industry Chain Analysis
7.2 Paclitaxel-Coated PTA Balloon Catheter Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel-Coated PTA Balloon Catheter Production Mode & Process
7.4 Paclitaxel-Coated PTA Balloon Catheter Sales and Marketing
7.4.1 Paclitaxel-Coated PTA Balloon Catheter Sales Channels
7.4.2 Paclitaxel-Coated PTA Balloon Catheter Distributors
7.5 Paclitaxel-Coated PTA Balloon Catheter Customers
8 Paclitaxel-Coated PTA Balloon Catheter Market Dynamics
8.1 Paclitaxel-Coated PTA Balloon Catheter Industry Trends
8.2 Paclitaxel-Coated PTA Balloon Catheter Market Drivers
8.3 Paclitaxel-Coated PTA Balloon Catheter Market Challenges
8.4 Paclitaxel-Coated PTA Balloon Catheter Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 131
USD 2900.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 108
USD 4250.00
(Single User License)
The global Paclitaxel-Coated PTA Balloon Catheter market is projected to grow from US$ 255 million in 2024 to US$ 354 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 171
USD 4900.00
(Single User License)
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 135
USD 3950.00
(Single User License)
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-01-13
Pages: 98
USD 2900.00
(Single User License)
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 150
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 131
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 108
The global Paclitaxel-Coated PTA Balloon Catheter market is projected to grow from US$ 255 million in 2024 to US$ 354 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 171
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 135
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-01-13
Pages: 98
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now